Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

ENVB

Enveric Biosciences (ENVB)

Enveric Biosciences Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ENVB
DateTimeSourceHeadlineSymbolCompany
09/26/20247:30AMBusiness WireEnveric Biosciences Presents Data Highlighting Development of EB-003 at European Behavioral Pharmacology Society Biennial WorkshopNASDAQ:ENVBEnveric Biosciences Inc
09/25/20247:30AMBusiness WireEnveric Biosciences Presents Data on Lead Product Candidate, EB-003, at 7th Neuropsychiatric Drug SummitNASDAQ:ENVBEnveric Biosciences Inc
09/12/20248:35AMEdgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:ENVBEnveric Biosciences Inc
09/11/202411:15PMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ENVBEnveric Biosciences Inc
09/04/20245:43PMEdgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:ENVBEnveric Biosciences Inc
09/04/20247:00AMBusiness WireEnveric Biosciences to Present at the H.C. Wainwright 26th Annual Global Investment ConferenceNASDAQ:ENVBEnveric Biosciences Inc
08/22/20247:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ENVBEnveric Biosciences Inc
08/13/20247:00AMBusiness WireAries Science & Technology and Enveric Biosciences Announce Issuance of Key US Patent Under Aries’ License for Treatment of Radiation Dermatitis and Other ConditionsNASDAQ:ENVBEnveric Biosciences Inc
08/12/20244:30PMBusiness WireEnveric Biosciences Reports Second Quarter 2024 Financial and Corporate ResultsNASDAQ:ENVBEnveric Biosciences Inc
08/12/20244:13PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ENVBEnveric Biosciences Inc
08/12/20244:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ENVBEnveric Biosciences Inc
07/25/20247:00AMBusiness WireEnveric Biosciences Announces Preclinical Results Confirming Potential of EB-003 to be Dosed OrallyNASDAQ:ENVBEnveric Biosciences Inc
07/15/20248:02AMBusiness WireAries Science & Technology and Enveric Biosciences Announce Licensing AgreementNASDAQ:ENVBEnveric Biosciences Inc
07/15/20247:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ENVBEnveric Biosciences Inc
07/10/20247:00AMBusiness WireEnveric Biosciences Announces Patent Granted for Drug CandidateNASDAQ:ENVBEnveric Biosciences Inc
07/08/20244:10PMEdgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:ENVBEnveric Biosciences Inc
06/25/20247:00AMBusiness WireEnveric Biosciences Provides Strategic Outlook and Pipeline Update, Elevating EB-003 to Lead Development CandidateNASDAQ:ENVBEnveric Biosciences Inc
06/03/20245:58PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:ENVBEnveric Biosciences Inc
06/03/20245:58PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:ENVBEnveric Biosciences Inc
05/30/20247:00AMBusiness WireEnveric Biosciences to Participate in BIO International Convention 2024NASDAQ:ENVBEnveric Biosciences Inc
05/29/20243:15PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ENVBEnveric Biosciences Inc
05/23/20247:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ENVBEnveric Biosciences Inc
05/17/20244:25PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ENVBEnveric Biosciences Inc
05/15/20245:00AMBusiness WireEnveric Biosciences Reports First Quarter 2024 Financial and Corporate ResultsNASDAQ:ENVBEnveric Biosciences Inc
05/14/20247:00AMBusiness WireEnveric Biosciences Signs $66.5 Million Non-Binding Term Sheet with MindBio Therapeutics to Out-License Novel Psilocin Prodrug Candidate for Mental Health DisordersNASDAQ:ENVBEnveric Biosciences Inc
05/08/20246:00AMBusiness WireEnveric Biosciences Announces Signing of Non-Binding Term Sheet with Undisclosed Licensee for Exclusive License to Patented Methods of Treating Breast and Other Cancers Using CannabinoidsNASDAQ:ENVBEnveric Biosciences Inc
03/26/20246:00AMBusiness WireEnveric Biosciences Reports Financial Results and Provides Corporate Update for Fourth Quarter and Fiscal Year Ended 2023NASDAQ:ENVBEnveric Biosciences Inc
03/19/20246:00AMBusiness WireEnveric Biosciences Signs Non-Binding Term Sheets to Pursue the Exclusive Out-Licensing of New Chemical Entities for Pharmaceutical and Non-Pharmaceutical Applications in Joint DiseaseNASDAQ:ENVBEnveric Biosciences Inc
03/12/20246:00AMBusiness WireEnveric Biosciences Announces New Patent Issuances Protecting Multiple Assets Covered by Non-Binding Term SheetsNASDAQ:ENVBEnveric Biosciences Inc
03/11/202411:35AMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:ENVBEnveric Biosciences Inc
 Showing the most relevant articles for your search:NASDAQ:ENVB